SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Most Read
1. NHG Health unveils Serangoon Polyclinic in Singapore 2. Chang Gung Hospital targets bigger Philippine patient base 3. Singapore–Malaysia medtech pilot seen luring more regional investment 4. Medical membranes market to be valued at $6.66b by 2030 5. SGH launches neuroscience ICU to support critical casesResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
